Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
Open Access
- 19 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e57282
Abstract
Loss-of-function mutations in the KCNQ4 channel cause DFNA2, a subtype of autosomal dominant non-syndromic deafness that is characterized by progressive sensorineural hearing loss. Previous studies have demonstrated that the majority of the pathogenic KCNQ4 mutations lead to trafficking deficiency and loss of KCNQ4 currents. Over the last two decades, various strategies have been developed to rescue trafficking deficiency of pathogenic mutants; the most exciting advances have been made by manipulating activities of molecular chaperones involved in the biogenesis and quality control of the target protein. However, such strategies have not been established for KCNQ4 mutants and little is known about the molecular chaperones governing the KCNQ4 biogenesis. To identify KCNQ4-associated molecular chaperones, a proteomic approach was used in this study. As a result, two major molecular chaperones, HSP70 and HSP90, were identified and then confirmed by reciprocal co-immunoprecipitation assays, suggesting that the HSP90 chaperone pathway might be involved in the KCNQ4 biogenesis. Manipulating chaperone expression further revealed that two different isoforms of HSP90, the inducible HSP90α and the constitutive HSP90β, had opposite effects on the cellular level of the KCNQ4 channel; that HSP40, HSP70, and HOP, three key components of the HSP90 chaperone pathway, were crucial in facilitating KCNQ4 biogenesis. In contrast, CHIP, a major E3 ubiquitin ligase, had an opposite effect. Collectively, our data suggest that HSP90α and HSP90β play key roles in controlling KCNQ4 homeostasis via the HSP40-HSP70-HOP-HSP90 chaperone pathway and the ubiquitin-proteasome pathway. Most importantly, we found that over-expression of HSP90β significantly improved cell surface expression of the trafficking-deficient, pathogenic KCNQ4 mutants L274H and W276S. KCNQ4 surface expression was restored by HSP90β in cells mimicking heterozygous conditions of the DFNA2 patients, even though it was not sufficient to rescue the function of KCNQ4 channels.Keywords
This publication has 52 references indexed in Scilit:
- Inhibiting HSP90 to Treat Cancer: A Strategy in EvolutionCurrent Molecular Medicine, 2012
- In silico modeling of the pore region of a KCNQ4 missense mutant from a patient with hearing lossBMC Research Notes, 2012
- Pathogenic effects of a novel mutation (c.664_681del) in KCNQ4 channels associated with auditory pathologyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Targeting the dynamic HSP90 complex in cancerNature Reviews Cancer, 2010
- Heat shock protein 90 in neurodegenerative diseasesMolecular Neurodegeneration, 2010
- Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locusGenetics in Medicine, 2008
- Identification of Novel Mutations in the KCNQ4 Gene of Patients with Nonsyndromic Deafness from TaiwanAudiology and Neurotology, 2006
- Phenotype Determination Guides Swift Genotyping of a DFNA2/KCNQ4 Family With a Hot Spot Mutation (W276S)Otology & Neurotology, 2005
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing lossHuman Mutation, 1999